Patents/Assignees

REGENXBIO Inc.

9 patents in portfolio

US12612644utility2026
Scalable Method for Recombinant AAV Production
0 cites
US12565645utility2026
Methods of Size Exclusion Chromatography for the Characterization of Recombinant Adeno-associated Virus Compositions
0 cites
US12365865utility2025
Scalable Clarification Process for Recombinant AAV Production
0 cites
US12247213utility2025
Treatment of Mucopolysaccharidosis IVA
0 cites
US12121567utility2024
Methods to Treat Mucopolysaccharidosis Type II or Deficiency in Iduronate-2-sulfatase Using a Recombinant Adeno-associated Virus (AAV) Vector Encoding Iduronate-2-sulfatase
0 cites
US12070510utility2024
Injection of Single-stranded or Self-complementary Adeno-associated Virus 9 Into the Cerebrospinal Fluid
0 cites
US12070702utility2024
Anion Exchange Chromatography for Recombinant AAV Production
0 cites
US11986515utility2024
Treatment of Mucopolysaccharidosis II with Recombinant Human Iduronate-2-sulfatase (IDS)
0 cites
US11613739utility2023
Treatment of Mucopolysaccharidosis II with Recombinant Human Iduronate-2-sulfatase (IDS) Produced by Human Neural or Glial Cells
0 cites